These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Clinical, cytogenetic, and molecular characterization of a girl with some clinical features of Down syndrome resulting from a pure partial trisomy 21q22.11-qter due to a de novo intrachromosomal duplication. Vaglio A; Milunsky A; Quadrelli A; Huang XL; Maher T; Mechoso B; Martínez S; Pagano S; Bellini S; Costabel M; Quadrelli R Genet Test Mol Biomarkers; 2010 Feb; 14(1):57-65. PubMed ID: 20143912 [TBL] [Abstract][Full Text] [Related]
23. Application of fluorescence in situ hybridization to the identification of different marker chromosomes. Verschraegen-Spae MR; Quack B; Rousseaux S; Pison H; Messiaen L; De Paepe A; Lespinasse J Ann Genet; 1998; 41(1):5-10. PubMed ID: 9599644 [TBL] [Abstract][Full Text] [Related]
24. [Prenatal chromosome analysis using the FISH technique allows fetal aneuploidy detection within a few hours]. Steinborn A; Röddiger S; Born HJ; Baier P; Halberstadt E Z Geburtshilfe Neonatol; 1996; 200(5):186-90. PubMed ID: 9035828 [TBL] [Abstract][Full Text] [Related]
25. Exploring polycythaemia vera with fluorescence in situ hybridization: additional cryptic 9p is the most frequent abnormality detected. Najfeld V; Montella L; Scalise A; Fruchtman S Br J Haematol; 2002 Nov; 119(2):558-66. PubMed ID: 12406101 [TBL] [Abstract][Full Text] [Related]
27. Transient myeloproliferative disorder with partial trisomy 21. Takahashi T; Inoue A; Yoshimoto J; Kanamitsu K; Taki T; Imada M; Yamada M; Ninomiya S; Toki T; Terui K; Ito E; Shimada A Pediatr Blood Cancer; 2015 Nov; 62(11):2021-4. PubMed ID: 26138905 [TBL] [Abstract][Full Text] [Related]
28. Clinical and cytogenetic characterisation of a patient with Down syndrome resulting from a 21q22.1-->qter duplication. Nadal M; Vigo CG; Melaragno MI; Andrade JA; Alonso LG; Brunoni D; Pritchard M; Estivill X J Med Genet; 2001 Jan; 38(1):73-6. PubMed ID: 11334012 [No Abstract] [Full Text] [Related]
29. Myeloproliferative disease of childhood associated with a trisomy 21 clone. Tabachnik E; Garty R; Zaizov R; Chemke J Acta Haematol; 1979; 62(2):90-3. PubMed ID: 119407 [TBL] [Abstract][Full Text] [Related]
30. [An analysis of human marker chromosomes originating from chromosome 21 by using in situ hybridization]. Zerova TE; Baronova EV; Gorovenko NG; Koblianskaia GN; Buzhievskaia TI; Vorsanova SG; Iurov IuB Tsitol Genet; 1995; 29(5):41-8. PubMed ID: 8721845 [TBL] [Abstract][Full Text] [Related]
31. Gain of 9p due to an unbalanced rearrangement der(9;18): a recurrent clonal abnormality in chronic myeloproliferative disorders. Bacher U; Haferlach T; Schoch C Cancer Genet Cytogenet; 2005 Jul; 160(2):179-83. PubMed ID: 15993276 [TBL] [Abstract][Full Text] [Related]
32. Tetrasomy 21 pter-->q22.1 and Down syndrome: molecular definition of the region. Daumer-Haas C; Schuffenhauer S; Walther JU; Schipper RD; Porstmann T; Korenberg JR Am J Med Genet; 1994 Dec; 53(4):359-65. PubMed ID: 7532356 [TBL] [Abstract][Full Text] [Related]
33. Molecular analysis of chromosome 21 in a patient with a phenotype of Down syndrome and apparently normal karyotype. Ahlbom BE; Goetz P; Korenberg JR; Pettersson U; Seemanova E; Wadelius C; Zech L; Annerén G Am J Med Genet; 1996 Jun; 63(4):566-72. PubMed ID: 8826436 [TBL] [Abstract][Full Text] [Related]
34. Clonal cell lineage involvement in myelodysplastic syndromes studied by fluorescence in situ hybridization and morphology. Bernell P; Jacobsson B; Nordgren A; Hast R Leukemia; 1996 Apr; 10(4):662-8. PubMed ID: 8618444 [TBL] [Abstract][Full Text] [Related]
35. Transient myeloproliferative syndrome/transient acute myeloid leukemia in a newborn with Down syndrome: a case report and literature review. D'Angelo G; Merlo P Lab Hematol; 2003; 9(1):38-41. PubMed ID: 12661826 [TBL] [Abstract][Full Text] [Related]
36. Chromosomal changes detected by fluorescence in situ hybridization in patients with acute lymphoblastic leukemia. Zhang L; Parkhurst JB; Kern WF; Scott KV; Niccum D; Mulvihill JJ; Li S Chin Med J (Engl); 2003 Sep; 116(9):1298-303. PubMed ID: 14527352 [TBL] [Abstract][Full Text] [Related]
37. Isolation of a cosmid clone corresponding to an inv(21) breakpoint of a patient with transient abnormal myelopoiesis. Ohta T; Nakano M; Tsujita T; Abe K; Osoegawa K; Yamagata T; Yoshiura K; Jinno Y; Soeda E; Nakamura Y; Niikawa N Am J Hum Genet; 1996 Mar; 58(3):544-50. PubMed ID: 8644714 [TBL] [Abstract][Full Text] [Related]
38. Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia. Rasillo A; Tabernero MD; Sánchez ML; Pérez de Andrés M; Martín Ayuso M; Hernández J; Moro MJ; Fernández-Calvo J; Sayagués JM; Bortoluci A; San Miguel JF; Orfao A Cancer; 2003 Feb; 97(3):601-9. PubMed ID: 12548602 [TBL] [Abstract][Full Text] [Related]
39. Prenatal diagnosis of trisomy 21 without the Down syndrome phenotype. Aguinaga M; Razo G; Castro J; Mayén-Molina DG Prenat Diagn; 2006 Dec; 26(12):1168-71. PubMed ID: 17042031 [TBL] [Abstract][Full Text] [Related]
40. Transient abnormal myelopoiesis of infancy associated with trisomy 21. Homans AC; Verissimo AM; Vlacha V Am J Pediatr Hematol Oncol; 1993 Nov; 15(4):392-9. PubMed ID: 8214361 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]